Estrogen and Graft Atherosclerosis Research Trial (EAGER)

• Status: Completed
• Trial end date: 2002-07-01
• Target enrollment: 0
• Participant gender: Female

Summary

To determine if postmenopausal hormone replacement therapy in women following coronary bypass surgery would reduce the occurrence of graft occlusion and delay the development of graft atherosclerosis.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
• Treatments: Estrogens; Hormones; Medroxyprogesterone; Medroxyprogesterone Acetate

Criteria

Postmenopausal women who had undergone coronary artery bypass graft.